JPWO2020081848A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020081848A5 JPWO2020081848A5 JP2021520556A JP2021520556A JPWO2020081848A5 JP WO2020081848 A5 JPWO2020081848 A5 JP WO2020081848A5 JP 2021520556 A JP2021520556 A JP 2021520556A JP 2021520556 A JP2021520556 A JP 2021520556A JP WO2020081848 A5 JPWO2020081848 A5 JP WO2020081848A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrido
- thio
- pyrazin
- amine
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 bicyclic aryl Chemical group 0.000 claims 74
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000002619 bicyclic group Chemical group 0.000 claims 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 3
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 230000003463 hyperproliferative effect Effects 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- XSYWQEZOMDPGFT-UHFFFAOYSA-N 3-chloro-4-[2-(3,8-diazabicyclo[3.2.1]octan-8-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CC2CNCC1N2C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl XSYWQEZOMDPGFT-UHFFFAOYSA-N 0.000 claims 2
- JYRWFZZKEKTMSK-UHFFFAOYSA-N decan-4-amine Chemical compound CCCCCCC(N)CCC JYRWFZZKEKTMSK-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 210000004214 philadelphia chromosome Anatomy 0.000 claims 2
- 125000003003 spiro group Chemical group 0.000 claims 2
- VRQDPNKOUPEWOC-UHFFFAOYSA-N spiro[bicyclo[2.2.2]octane-3,3'-piperidine] Chemical compound C1CCNCC21C(CC1)CCC1C2 VRQDPNKOUPEWOC-UHFFFAOYSA-N 0.000 claims 2
- OZSKKNLHNCVVTE-QFIPXVFZSA-N (1R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-chlorospiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@H](C2=CC=CC(=C2C3)Cl)N)N=1 OZSKKNLHNCVVTE-QFIPXVFZSA-N 0.000 claims 1
- LARREPGAAVKCCX-QHCPKHFHSA-N (1R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylspiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound CC1=C2CC3(CCN(CC3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl)[C@H](C2=CC=C1)N LARREPGAAVKCCX-QHCPKHFHSA-N 0.000 claims 1
- YPLHAXDRIIJALD-QFIPXVFZSA-N (1R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-5-chlorospiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound C1CN(CCC12CC3=C([C@@H]2N)C=CC(=C3)Cl)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl YPLHAXDRIIJALD-QFIPXVFZSA-N 0.000 claims 1
- ZJCWKDUZVMTXRX-QHCPKHFHSA-N (1R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-6-methylspiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound CC1=CC2=C(CC3([C@H]2N)CCN(CC3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl)C=C1 ZJCWKDUZVMTXRX-QHCPKHFHSA-N 0.000 claims 1
- DMGHTRNPFCSYPI-HXUWFJFHSA-N (1R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,3'-azetidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CC3([C@@H](C4=CC=CC=C4C3)N)C2)N=1 DMGHTRNPFCSYPI-HXUWFJFHSA-N 0.000 claims 1
- NYADKSCWULBOJD-JFGNBEQYSA-N (1R,5R,6S)-3-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-8-oxa-3-azabicyclo[3.2.1]octan-6-amine Chemical compound C1[C@@H]2CN(C[C@H]([C@H]1N)O2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl NYADKSCWULBOJD-JFGNBEQYSA-N 0.000 claims 1
- OZSKKNLHNCVVTE-JOCHJYFZSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-chlorospiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=CC(=C2C3)Cl)N)N=1 OZSKKNLHNCVVTE-JOCHJYFZSA-N 0.000 claims 1
- LARREPGAAVKCCX-HSZRJFAPSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylspiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=CC(=C2C3)C)N)N=1 LARREPGAAVKCCX-HSZRJFAPSA-N 0.000 claims 1
- LCDKHVMBHOTRTK-JOCHJYFZSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-5-fluorospiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=C(C=C2C3)F)N)N=1 LCDKHVMBHOTRTK-JOCHJYFZSA-N 0.000 claims 1
- XSVLQUPXLDCENB-HSZRJFAPSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-6-methoxyspiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound COC1=CC2=C(CC3([C@@H]2N)CCN(CC3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl)C=C1 XSVLQUPXLDCENB-HSZRJFAPSA-N 0.000 claims 1
- ZJCWKDUZVMTXRX-HSZRJFAPSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-6-methylspiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound CC1=CC2=C(CC3([C@@H]2N)CCN(CC3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl)C=C1 ZJCWKDUZVMTXRX-HSZRJFAPSA-N 0.000 claims 1
- DMGHTRNPFCSYPI-FQEVSTJZSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,3'-azetidine]-1-amine Chemical compound C1C2=CC=CC=C2[C@@H](C13CN(C3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl)N DMGHTRNPFCSYPI-FQEVSTJZSA-N 0.000 claims 1
- XNIYTWAJXXHCLG-JOCHJYFZSA-N (1S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=CC=C2C3)N)N=1 XNIYTWAJXXHCLG-JOCHJYFZSA-N 0.000 claims 1
- ULUKTOYTLCREPI-HSZRJFAPSA-N (1S)-1'-[6-(6-amino-3-chloro-2-methoxypyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound COC1=C(C(=CC(=N1)N)SC2=NC3=NC=C(N=C3C=C2)N4CCC5(CC4)CC6=CC=CC=C6[C@H]5N)Cl ULUKTOYTLCREPI-HSZRJFAPSA-N 0.000 claims 1
- WFBKCTDJMVCMAR-JOCHJYFZSA-N (1S)-1'-[6-(6-amino-4,5-dichloropyridin-3-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound NC1=C(C(=C(C=N1)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=CC=C2C3)N)N=1)Cl)Cl WFBKCTDJMVCMAR-JOCHJYFZSA-N 0.000 claims 1
- ZMTQXYGXNBYNLQ-RUZDIDTESA-N (1S)-1'-[6-(6-chloroimidazo[1,2-a]pyridin-3-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound ClC=1C=CC=2N(C=1)C(=CN=2)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C2=CC=CC=C2C3)N)N=1 ZMTQXYGXNBYNLQ-RUZDIDTESA-N 0.000 claims 1
- CMFWOJVHVWLDQX-JOCHJYFZSA-N (1S)-1'-[6-[2-(trifluoromethyl)pyridin-3-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-1-amine Chemical compound C1CN(CCC12CC3=CC=CC=C3[C@H]2N)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(N=CC=C6)C(F)(F)F CMFWOJVHVWLDQX-JOCHJYFZSA-N 0.000 claims 1
- NSEIQYVDCNVFFR-XMMPIXPASA-N (1S)-1-amino-1'-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-5-ol Chemical compound N[C@@H]1C2=CC=C(C=C2CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)C)Cl)O NSEIQYVDCNVFFR-XMMPIXPASA-N 0.000 claims 1
- LANVDWAEBRQKDI-SWLSCSKDSA-N (2R,4R)-4-amino-8-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-2-ol Chemical compound C1CN(CCC12C[C@H](C[C@H]2N)O)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl LANVDWAEBRQKDI-SWLSCSKDSA-N 0.000 claims 1
- GYKBBFLZXIYTLN-OAQYLSRUSA-N (3R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[3H-1-benzofuran-2,4'-piperidine]-3-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)OC2=C([C@H]3N)C=CC=C2)N=1 GYKBBFLZXIYTLN-OAQYLSRUSA-N 0.000 claims 1
- VPJXWCALBDMBRW-WJONJSRFSA-N (3R)-1-[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]pyrrolidin-3-ol Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N6CC[C@H](C6)O)Cl)CO1)N VPJXWCALBDMBRW-WJONJSRFSA-N 0.000 claims 1
- CXAJPNYARDLNEG-QHCPKHFHSA-N (3R)-3-amino-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-5-carbonitrile Chemical compound N[C@H]1C2=CC(=CC=C2CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)C#N CXAJPNYARDLNEG-QHCPKHFHSA-N 0.000 claims 1
- VPJXWCALBDMBRW-PONJGIIJSA-N (3S)-1-[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]pyrrolidin-3-ol Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N1C[C@H](CC1)O)Cl)C VPJXWCALBDMBRW-PONJGIIJSA-N 0.000 claims 1
- CXAJPNYARDLNEG-HSZRJFAPSA-N (3S)-3-amino-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[1,3-dihydroindene-2,4'-piperidine]-5-carbonitrile Chemical compound N[C@@H]1C2=CC(=CC=C2CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)C#N CXAJPNYARDLNEG-HSZRJFAPSA-N 0.000 claims 1
- QDHGFXBJOHKTTK-YCRPNKLZSA-N (3S,4S)-3-methyl-8-[6-(1-methylpyrrolo[2,3-b]pyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C6C=CN(C6=NC=C5)C)CO1)N QDHGFXBJOHKTTK-YCRPNKLZSA-N 0.000 claims 1
- LXGHMQNLASTXAL-VBKZILBWSA-N (3S,4S)-3-methyl-8-[6-(1H-pyrrolo[2,3-b]pyridin-4-ylsulfanyl)pyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C6C=CNC6=NC=C5)CO1)N LXGHMQNLASTXAL-VBKZILBWSA-N 0.000 claims 1
- RWSIRNVELKSHRS-YCRPNKLZSA-N (3S,4S)-3-methyl-8-[6-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@@H]1OCC2([C@@H]1N)CCN(CC2)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C2C(=NC=C1)NC=C2C RWSIRNVELKSHRS-YCRPNKLZSA-N 0.000 claims 1
- LUUDQBCPMCEOKS-SCLBCKFNSA-N (3S,4S)-3-methyl-8-[6-[2-(trifluoromethyl)pyridin-3-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(N=CC=C5)C(F)(F)F)CO1)N LUUDQBCPMCEOKS-SCLBCKFNSA-N 0.000 claims 1
- IRWAOMZOLYCRJH-ORAYPTAESA-N (3S,4S)-3-methyl-8-[6-[2-(trifluoromethyl)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=CC(=NC=C5)C(F)(F)F)CO1)N IRWAOMZOLYCRJH-ORAYPTAESA-N 0.000 claims 1
- GXWAZAAAKHRHCN-ORAYPTAESA-N (3S,4S)-3-methyl-8-[6-[3-(trifluoromethyl)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C=NC=C5)C(F)(F)F)CO1)N GXWAZAAAKHRHCN-ORAYPTAESA-N 0.000 claims 1
- GMLFRCSSZBAEEL-RNODOKPDSA-N (3S,4S)-3-methyl-8-[6-[[5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]sulfanyl]pyrido[2,3-b]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C6C=CNC6=NC=C5C(F)(F)F)CO1)N GMLFRCSSZBAEEL-RNODOKPDSA-N 0.000 claims 1
- FGWGNCYBMDTWKY-ORAYPTAESA-N (3S,4S)-8-[6-(1H-imidazo[4,5-b]pyridin-7-ylsulfanyl)pyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound N1=CNC2=NC=CC(=C21)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 FGWGNCYBMDTWKY-ORAYPTAESA-N 0.000 claims 1
- FXXHWOXEFPTYFG-KPZWWZAWSA-N (3S,4S)-8-[6-(2,3-dichloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)Cl)Cl)CO1)N FXXHWOXEFPTYFG-KPZWWZAWSA-N 0.000 claims 1
- LBDMGVFWRXPVGX-HRAATJIYSA-N (3S,4S)-8-[6-(2,3-dimethylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)C)C)CO1)N LBDMGVFWRXPVGX-HRAATJIYSA-N 0.000 claims 1
- CNWPAKCFVFDYQN-KPZWWZAWSA-N (3S,4S)-8-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 CNWPAKCFVFDYQN-KPZWWZAWSA-N 0.000 claims 1
- KWECHTNMZUVGJX-KPZWWZAWSA-N (3S,4S)-8-[6-(2-amino-3-fluoropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)F)CO1)N KWECHTNMZUVGJX-KPZWWZAWSA-N 0.000 claims 1
- YUDIARZXLVJNKY-ORAYPTAESA-N (3S,4S)-8-[6-(2-amino-3-methoxypyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=NC=CC(=C1OC)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 YUDIARZXLVJNKY-ORAYPTAESA-N 0.000 claims 1
- YXVJUSOEWJOJLQ-IFXJQAMLSA-N (3S,4S)-8-[6-(2-amino-3-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=NC=CC(=C1C)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 YXVJUSOEWJOJLQ-IFXJQAMLSA-N 0.000 claims 1
- FRMOYPZKSNSGRE-HXPMCKFVSA-N (3S,4S)-8-[6-(2-amino-5-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=NC=C(C(=C1)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1)Cl FRMOYPZKSNSGRE-HXPMCKFVSA-N 0.000 claims 1
- WZJVWFHSVVHPOS-KSFYIVLOSA-N (3S,4S)-8-[6-(3-chloro-2-morpholin-4-ylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1)N1CCOCC1 WZJVWFHSVVHPOS-KSFYIVLOSA-N 0.000 claims 1
- JSHRRIDKNPDAEB-KSFYIVLOSA-N (3S,4S)-8-[6-(3-chloro-2-pyrrolidin-1-ylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N6CCCC6)Cl)CO1)N JSHRRIDKNPDAEB-KSFYIVLOSA-N 0.000 claims 1
- TYNAIVGURYTUIF-ORAYPTAESA-N (3S,4S)-8-[6-(3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C=NC=C5)Cl)CO1)N TYNAIVGURYTUIF-ORAYPTAESA-N 0.000 claims 1
- ISLMPGAQDNQHAQ-ORAYPTAESA-N (3S,4S)-8-[6-(3-fluoropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C=NC=C5)F)CO1)N ISLMPGAQDNQHAQ-ORAYPTAESA-N 0.000 claims 1
- NVXSXSPUVVVHID-BBATYDOGSA-N (3S,4S)-8-[6-(6-amino-2,3-dichloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=CC(=C(C(=N1)Cl)Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 NVXSXSPUVVVHID-BBATYDOGSA-N 0.000 claims 1
- MIXKRLZSTGZOTJ-KPZWWZAWSA-N (3S,4S)-8-[6-(6-amino-2-chloropyridin-3-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(N=C(C=C5)N)Cl)CO1)N MIXKRLZSTGZOTJ-KPZWWZAWSA-N 0.000 claims 1
- YPEHLJMUFJTGOE-MEDUHNTESA-N (3S,4S)-8-[6-(6-amino-5-chloropyrimidin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=NC=NC(=C5Cl)N)CO1)N YPEHLJMUFJTGOE-MEDUHNTESA-N 0.000 claims 1
- KRMALMVEPLKLKV-RNODOKPDSA-N (3S,4S)-8-[6-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C6C=CNC6=NC=C5Cl)CO1)N KRMALMVEPLKLKV-RNODOKPDSA-N 0.000 claims 1
- WCGYCOKDOPJEDY-RNODOKPDSA-N (3S,4S)-8-[6-[(5-fluoro-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound FC=1C(=C2C(=NC=1)NC=C2)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 WCGYCOKDOPJEDY-RNODOKPDSA-N 0.000 claims 1
- VSFPSZKXWKIBDM-RNODOKPDSA-N (3S,4S)-8-[6-[(6-amino-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=CC(=C2C(=N1)NC=C2)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 VSFPSZKXWKIBDM-RNODOKPDSA-N 0.000 claims 1
- IOCAWKYQBONCDW-KPZWWZAWSA-N (3S,4S)-8-[6-[2-amino-3-(trifluoromethyl)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound NC1=NC=CC(=C1C(F)(F)F)SC=1C=CC=2C(=NC=C(N=2)N2CCC3([C@@H]([C@@H](OC3)C)N)CC2)N=1 IOCAWKYQBONCDW-KPZWWZAWSA-N 0.000 claims 1
- SOVXIBFUINKCQA-KSFYIVLOSA-N (3S,4S)-8-[6-[3-chloro-2-(1,1-dioxo-1,4-thiazinan-4-yl)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N1CCS(CC1)(=O)=O)Cl)C SOVXIBFUINKCQA-KSFYIVLOSA-N 0.000 claims 1
- IRZMBGVQAVOUHZ-YCRPNKLZSA-N (3S,4S)-8-[6-[3-chloro-2-(2-methoxyethylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)NCCOC)Cl)CO1)N IRZMBGVQAVOUHZ-YCRPNKLZSA-N 0.000 claims 1
- XINAXVKXQPQSFK-LHSJRXKWSA-N (3S,4S)-8-[6-[3-chloro-2-(cyclopropylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)NC6CC6)Cl)CO1)N XINAXVKXQPQSFK-LHSJRXKWSA-N 0.000 claims 1
- FCHPLJDSLAZVNU-ORAYPTAESA-N (3S,4S)-8-[6-[3-chloro-2-(methylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)NC)Cl)CO1)N FCHPLJDSLAZVNU-ORAYPTAESA-N 0.000 claims 1
- RNKVBMKFYWSEAQ-KPZWWZAWSA-N (3S,4S)-8-[6-[6-amino-2-(trifluoromethyl)pyridin-3-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(N=C(C=C5)N)C(F)(F)F)CO1)N RNKVBMKFYWSEAQ-KPZWWZAWSA-N 0.000 claims 1
- KRZJRNZICWNMOA-GXSJLCMTSA-N (3s,4r)-4,8-dihydroxy-3-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1=CC=C2[C@@H](O)[C@@H](OC)CC(=O)C2=C1O KRZJRNZICWNMOA-GXSJLCMTSA-N 0.000 claims 1
- FZVBBQYCZSPLJL-LJQANCHMSA-N (4R)-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CC[C@@](CCC2)(N)C)N=1 FZVBBQYCZSPLJL-LJQANCHMSA-N 0.000 claims 1
- ZLEYPUJZZGTSLW-LLVKDONJSA-N (4R)-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]azepan-4-amine Chemical compound C1C[C@H](CCN(C1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N ZLEYPUJZZGTSLW-LLVKDONJSA-N 0.000 claims 1
- FQFIIOPXGVUALB-HXUWFJFHSA-N (4R)-1-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CC[C@@](CCC2)(N)C)N=1)C FQFIIOPXGVUALB-HXUWFJFHSA-N 0.000 claims 1
- BBERCTWLTZSEGW-HXUWFJFHSA-N (4R)-1-[6-[3-chloro-2-(methylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CC[C@@](CCC2)(N)C)N=1)NC BBERCTWLTZSEGW-HXUWFJFHSA-N 0.000 claims 1
- MODFWBDEFHGHST-QGZVFWFLSA-N (4R)-8-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine Chemical compound ClC1=C(C=CC=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CCC[C@H]3N)CC2)N=1 MODFWBDEFHGHST-QGZVFWFLSA-N 0.000 claims 1
- FZVBBQYCZSPLJL-IBGZPJMESA-N (4S)-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CC[C@](CCC2)(N)C)N=1 FZVBBQYCZSPLJL-IBGZPJMESA-N 0.000 claims 1
- BCQILAUZDDKPDF-LBPRGKRZSA-N (4S)-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-N-methylazepan-4-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CC[C@H](CCC2)NC)N=1 BCQILAUZDDKPDF-LBPRGKRZSA-N 0.000 claims 1
- ZLEYPUJZZGTSLW-NSHDSACASA-N (4S)-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]azepan-4-amine Chemical compound C1C[C@@H](CCN(C1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N ZLEYPUJZZGTSLW-NSHDSACASA-N 0.000 claims 1
- FQFIIOPXGVUALB-FQEVSTJZSA-N (4S)-1-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CC[C@](CCC2)(N)C)N=1)C FQFIIOPXGVUALB-FQEVSTJZSA-N 0.000 claims 1
- BBERCTWLTZSEGW-FQEVSTJZSA-N (4S)-1-[6-[3-chloro-2-(methylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CC[C@](CCC2)(N)C)N=1)NC BBERCTWLTZSEGW-FQEVSTJZSA-N 0.000 claims 1
- ZSLYUFDRBWEENT-QFIPXVFZSA-N (5R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-methoxyspiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@H](C=2C(=NC(=CC=2)OC)C3)N)N=1 ZSLYUFDRBWEENT-QFIPXVFZSA-N 0.000 claims 1
- RFYWVDVFMZNBBB-QFIPXVFZSA-N (5R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-methylspiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@H](C=2C(=NC(=CC=2)C)C3)N)N=1 RFYWVDVFMZNBBB-QFIPXVFZSA-N 0.000 claims 1
- URLQCJFKEIJEMW-NRFANRHFSA-N (5R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-fluorospiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@H](C=2C(=NC=C(C=2)F)C3)N)N=1 URLQCJFKEIJEMW-NRFANRHFSA-N 0.000 claims 1
- BWQAQACZKDLJAW-NRFANRHFSA-N (5R)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound C1CN(CCC12CC3=C([C@@H]2N)C=CC=N3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl BWQAQACZKDLJAW-NRFANRHFSA-N 0.000 claims 1
- RFYWVDVFMZNBBB-JOCHJYFZSA-N (5S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-methylspiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C=2C(=NC(=CC=2)C)C3)N)N=1 RFYWVDVFMZNBBB-JOCHJYFZSA-N 0.000 claims 1
- URLQCJFKEIJEMW-OAQYLSRUSA-N (5S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-fluorospiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C=2C(=NC=C(C=2)F)C3)N)N=1 URLQCJFKEIJEMW-OAQYLSRUSA-N 0.000 claims 1
- BBHOXURWAZHPOP-JOCHJYFZSA-N (5S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3-methoxyspiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C=2C(=NC=C(C=2)OC)C3)N)N=1 BBHOXURWAZHPOP-JOCHJYFZSA-N 0.000 claims 1
- BWQAQACZKDLJAW-OAQYLSRUSA-N (5S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C=2C(=NC=CC=2)C3)N)N=1 BWQAQACZKDLJAW-OAQYLSRUSA-N 0.000 claims 1
- QZDIZZWLGDHWLW-JOCHJYFZSA-N (5S)-1'-[6-(2-amino-5-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound NC1=NC=C(C(=C1)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)[C@@H](C=2C(=NC=CC=2)C3)N)N=1)Cl QZDIZZWLGDHWLW-JOCHJYFZSA-N 0.000 claims 1
- QOGBWRCHPIOLJU-OAQYLSRUSA-N (5S)-1'-[6-[2-(trifluoromethyl)pyridin-3-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine Chemical compound C1CN(CCC12CC3=C([C@H]2N)C=CC=N3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(N=CC=C6)C(F)(F)F QOGBWRCHPIOLJU-OAQYLSRUSA-N 0.000 claims 1
- QMIMHUDEVKGOTQ-DVQDXYAYSA-N (e)-n-[(1s)-1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylprop-2-enamide Chemical compound N([C@@H](C)C=1C=C(C=CC=1)N1CCOCC1)C(=O)\C=C\C1=CC=CC=C1 QMIMHUDEVKGOTQ-DVQDXYAYSA-N 0.000 claims 1
- RQTAAUPFFCLFOR-UHFFFAOYSA-N 1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-7-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC3(CC2)CC=2C(=NC=CC=2)C3N)N=1 RQTAAUPFFCLFOR-UHFFFAOYSA-N 0.000 claims 1
- GPJJNZUUUIPEMK-UHFFFAOYSA-N 1-(6-isoquinolin-8-ylsulfanylpyrido[2,3-b]pyrazin-2-yl)-4-methylpiperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=CC=CC5=C4C=NC=C5)N GPJJNZUUUIPEMK-UHFFFAOYSA-N 0.000 claims 1
- XQYFPDMLVHPFSK-UHFFFAOYSA-N 1-[2-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-6-yl]-4-methylpiperidin-4-amine Chemical compound ClC1=C(C=CC=C1Cl)SC=1N=C2C(=NC=1)N=C(C=C2)N1CCC(CC1)(N)C XQYFPDMLVHPFSK-UHFFFAOYSA-N 0.000 claims 1
- CXPZZFXDJJNRRZ-QMHKHESXSA-N 1-[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]piperidin-4-ol Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N1CCC(CC1)O)Cl)C CXPZZFXDJJNRRZ-QMHKHESXSA-N 0.000 claims 1
- VPJXWCALBDMBRW-RYVCVBLFSA-N 1-[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]pyrrolidin-3-ol Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N1CC(CC1)O)Cl)C VPJXWCALBDMBRW-RYVCVBLFSA-N 0.000 claims 1
- HMAGSPHSAACAHH-AREMUKBSSA-N 1-[4-[2-[(5S)-5-aminospiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-1'-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]piperidin-4-ol Chemical compound C1CN(CCC1O)C2=NC=CC(=C2Cl)SC3=NC4=NC=C(N=C4C=C3)N5CCC6(CC5)CC7=C([C@H]6N)C=CC=N7 HMAGSPHSAACAHH-AREMUKBSSA-N 0.000 claims 1
- MXKQDUJAJANSQW-BXKMTCNYSA-N 1-[4-[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]piperazin-1-yl]ethanone Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N1CCN(CC1)C(C)=O)Cl)C MXKQDUJAJANSQW-BXKMTCNYSA-N 0.000 claims 1
- BXQZLCWOFRAYLD-UHFFFAOYSA-N 1-[4-amino-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]-2-methylpropan-2-ol Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)CC(C)(O)C BXQZLCWOFRAYLD-UHFFFAOYSA-N 0.000 claims 1
- FMYQGMKUTVEFSA-UHFFFAOYSA-N 1-[6-(2,3-dichlorophenyl)sulfanyl-3-methylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound ClC1=C(C=CC=C1Cl)SC=1C=CC=2C(=NC(=C(N=2)N2CCC(CC2)(N)C)C)N=1 FMYQGMKUTVEFSA-UHFFFAOYSA-N 0.000 claims 1
- ACCDLDCDCLNKCH-UHFFFAOYSA-N 1-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound ClC1=C(C=CC=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC(CC2)(N)C)N=1 ACCDLDCDCLNKCH-UHFFFAOYSA-N 0.000 claims 1
- ZINVKVAFUWFHBK-UHFFFAOYSA-N 1-[6-(2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-ylsulfanyl)pyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C5CCNC5=NC=C4)N ZINVKVAFUWFHBK-UHFFFAOYSA-N 0.000 claims 1
- WSUOCZGUYHEYNI-UHFFFAOYSA-N 1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-(aminomethyl)piperidin-4-ol Chemical compound C1CN(CCC1(CN)O)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl WSUOCZGUYHEYNI-UHFFFAOYSA-N 0.000 claims 1
- HWFDVTCVDFUHGR-UHFFFAOYSA-N 1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-(hydroxymethyl)piperidin-4-ol Chemical compound C1CN(CCC1(CO)O)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl HWFDVTCVDFUHGR-UHFFFAOYSA-N 0.000 claims 1
- FZVBBQYCZSPLJL-UHFFFAOYSA-N 1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC(CCC2)(N)C)N=1 FZVBBQYCZSPLJL-UHFFFAOYSA-N 0.000 claims 1
- IPILYXRPIMXNGK-UHFFFAOYSA-N 1-[6-(2-chloro-3-methoxyphenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound ClC1=C(C=CC=C1OC)SC=1C=CC=2C(=NC=C(N=2)N2CCC(CC2)(N)C)N=1 IPILYXRPIMXNGK-UHFFFAOYSA-N 0.000 claims 1
- MIIQIFPBEYQHGO-UHFFFAOYSA-N 1-[6-(2-chloro-6-methylpyridin-3-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1=NC(=C(C=C1)SC2=NC3=NC=C(N=C3C=C2)N4CCC(CC4)(C)N)Cl MIIQIFPBEYQHGO-UHFFFAOYSA-N 0.000 claims 1
- SEYQXKIRSCBUBZ-UHFFFAOYSA-N 1-[6-(3-chloro-2-methoxypyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)OC)Cl)N SEYQXKIRSCBUBZ-UHFFFAOYSA-N 0.000 claims 1
- FQFIIOPXGVUALB-UHFFFAOYSA-N 1-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CCC(CCC2)(N)C)N=1)C FQFIIOPXGVUALB-UHFFFAOYSA-N 0.000 claims 1
- GUZGJMYCVKOBKN-UHFFFAOYSA-N 1-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1=NC=CC(=C1Cl)SC2=NC3=NC=C(N=C3C=C2)N4CCC(CC4)(C)N GUZGJMYCVKOBKN-UHFFFAOYSA-N 0.000 claims 1
- XMUUMKWQHBUMQO-UHFFFAOYSA-N 1-[6-(3-chloro-2-pyrrolidin-1-ylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N5CCCC5)Cl)N XMUUMKWQHBUMQO-UHFFFAOYSA-N 0.000 claims 1
- HQIHMZGRWZACSC-UHFFFAOYSA-N 1-[6-(6-chloro-2-methylpyridin-3-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylpiperidin-4-amine Chemical compound CC1=C(C=CC(=N1)Cl)SC2=NC3=NC=C(N=C3C=C2)N4CCC(CC4)(C)N HQIHMZGRWZACSC-UHFFFAOYSA-N 0.000 claims 1
- BBERCTWLTZSEGW-UHFFFAOYSA-N 1-[6-[3-chloro-2-(methylamino)pyridin-4-yl]sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-methylazepan-4-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CCC(CCC2)(N)C)N=1)NC BBERCTWLTZSEGW-UHFFFAOYSA-N 0.000 claims 1
- XXJGBENTLXFVFI-UHFFFAOYSA-N 1-amino-methylene Chemical compound N[CH2] XXJGBENTLXFVFI-UHFFFAOYSA-N 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- WRENRJMJIHUTIX-UHFFFAOYSA-N 2-[1-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]propan-2-amine Chemical compound CC(C)(C1CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=CC=C4)Cl)Cl)N WRENRJMJIHUTIX-UHFFFAOYSA-N 0.000 claims 1
- YBVDWSJSVOOQIO-UHFFFAOYSA-N 2-[4-amino-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]ethanol Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)CCO YBVDWSJSVOOQIO-UHFFFAOYSA-N 0.000 claims 1
- MDYKAMQEOWZYLK-UHFFFAOYSA-N 2-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-4-amine Chemical compound C1CC2CN(CC2C(C1)N)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl MDYKAMQEOWZYLK-UHFFFAOYSA-N 0.000 claims 1
- CSNZEUQNLJIHLP-UHFFFAOYSA-N 2-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-2-azaspiro[4.4]nonan-9-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CC3(CC2)C(CCC3)N)N=1 CSNZEUQNLJIHLP-UHFFFAOYSA-N 0.000 claims 1
- QWZOMAKYROFRHU-UHFFFAOYSA-N 2-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-4-amine Chemical compound C1CC(C2C1CN(C2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl)N QWZOMAKYROFRHU-UHFFFAOYSA-N 0.000 claims 1
- KCZQYXBBWPVVTJ-XMMPIXPASA-N 2-[[4-[2-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]amino]ethanol Chemical compound N[C@@H]1C2=CC=CC=C2CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)NCCO)Cl KCZQYXBBWPVVTJ-XMMPIXPASA-N 0.000 claims 1
- LKQRDIRHKXOEME-VBKZILBWSA-N 2-[[4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]amino]ethanol Chemical compound C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)NCCO)Cl)CO1)N LKQRDIRHKXOEME-VBKZILBWSA-N 0.000 claims 1
- ZXJUEBLQDLTZRR-HSZRJFAPSA-N 2-[[4-[2-[(5S)-5-aminospiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-1'-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]amino]ethanol Chemical compound N[C@@H]1C=2C(=NC=CC=2)CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)NCCO)Cl ZXJUEBLQDLTZRR-HSZRJFAPSA-N 0.000 claims 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 1
- RMZKUOVRTWVBDH-UHFFFAOYSA-N 3-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-2-chlorobenzonitrile Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=CC=CC(=C4Cl)C#N)N RMZKUOVRTWVBDH-UHFFFAOYSA-N 0.000 claims 1
- VRESSEKOHFBFMJ-UHFFFAOYSA-N 3-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(N=CC=C4)N)N VRESSEKOHFBFMJ-UHFFFAOYSA-N 0.000 claims 1
- PVIGQAXTNIQQPV-AREMUKBSSA-N 3-[2-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanylimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1CN(CCC12CC3=CC=CC=C3[C@H]2N)C4=CN=C5C(=N4)C=CC(=N5)SC6=CN=C7N6C=C(C=C7)C#N PVIGQAXTNIQQPV-AREMUKBSSA-N 0.000 claims 1
- QIUNMDDHEBTHST-UHFFFAOYSA-N 3-[[4-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]amino]-2,2-dimethylpropanenitrile Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)NCC(C#N)(C)C)Cl)C QIUNMDDHEBTHST-UHFFFAOYSA-N 0.000 claims 1
- PAQFJNYIRRWONY-UHFFFAOYSA-N 3-chloro-4-[2-(1,7-diazaspiro[3.5]nonan-7-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CNC12CCN(CC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl PAQFJNYIRRWONY-UHFFFAOYSA-N 0.000 claims 1
- YMRXFMBVJYTKFT-UHFFFAOYSA-N 3-chloro-4-[2-(2,7-diazaspiro[3.5]nonan-7-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CN(CCC12CNC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl YMRXFMBVJYTKFT-UHFFFAOYSA-N 0.000 claims 1
- FSZFKPLZHJFJCJ-UHFFFAOYSA-N 3-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-3-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1C2CN(CC1N2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl FSZFKPLZHJFJCJ-UHFFFAOYSA-N 0.000 claims 1
- SOHXKKAKXVUBSO-UHFFFAOYSA-N 3-chloro-4-[2-(3,6-diazabicyclo[3.2.2]nonan-6-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CC2CNCC1CN2C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl SOHXKKAKXVUBSO-UHFFFAOYSA-N 0.000 claims 1
- UXHCPSRMVXZAFQ-UHFFFAOYSA-N 3-chloro-4-[2-(3,7-diazabicyclo[4.2.0]octan-3-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CN(CC2C1NC2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl UXHCPSRMVXZAFQ-UHFFFAOYSA-N 0.000 claims 1
- VZDSCCRIJOCJNG-UHFFFAOYSA-N 3-chloro-4-[2-(3,8-diazabicyclo[3.2.1]octan-3-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1CC2CN(CC1N2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl VZDSCCRIJOCJNG-UHFFFAOYSA-N 0.000 claims 1
- XYMKTHVLYWAOHT-UHFFFAOYSA-N 3-chloro-4-[2-(3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1C2COCC(N2)CN1C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl XYMKTHVLYWAOHT-UHFFFAOYSA-N 0.000 claims 1
- LZTKWZDLNVREEY-UHFFFAOYSA-N 3-chloro-4-[2-(4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound ClC=1C(=NC=CC=1SC=1C=CC=2C(=NC=C(N=2)N2CCC(CC2)C)N=1)N LZTKWZDLNVREEY-UHFFFAOYSA-N 0.000 claims 1
- JUXSIPYWXSPZIG-UHFFFAOYSA-N 3-chloro-4-[2-(9-oxa-3,7-diazabicyclo[3.3.1]nonan-3-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1C2CN(CC(O2)CN1)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl JUXSIPYWXSPZIG-UHFFFAOYSA-N 0.000 claims 1
- KBCXDHILLZQNOQ-UWVGGRQHSA-N 3-chloro-4-[2-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1[C@H]2CN[C@@H]1CN2C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl KBCXDHILLZQNOQ-UWVGGRQHSA-N 0.000 claims 1
- ITWBGUGSTRIZHR-QWRGUYRKSA-N 3-chloro-4-[2-[(1S,4S)-2,5-diazabicyclo[2.2.2]octan-2-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound C1C[C@H]2CN([C@@H]1CN2)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl ITWBGUGSTRIZHR-QWRGUYRKSA-N 0.000 claims 1
- GSOVNVHPLHWGDA-UHFFFAOYSA-N 3-chloro-4-[2-[4-methyl-4-(methylamino)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanylpyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)NC GSOVNVHPLHWGDA-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- BZOYVPQGHYJEEH-UHFFFAOYSA-N 4-[2-(4-amino-4-benzylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1CN(CCC1(CC2=CC=CC=C2)N)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl BZOYVPQGHYJEEH-UHFFFAOYSA-N 0.000 claims 1
- ORTHFDUDUPMEHN-UHFFFAOYSA-N 4-[2-(4-amino-4-ethylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)CC ORTHFDUDUPMEHN-UHFFFAOYSA-N 0.000 claims 1
- XLEFVIBYHOPBHW-UHFFFAOYSA-N 4-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloro-N-(2-methoxyethyl)pyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)NCCOC)Cl)N XLEFVIBYHOPBHW-UHFFFAOYSA-N 0.000 claims 1
- LNYPPWSTAATSNO-UHFFFAOYSA-N 4-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloro-N-(3-methoxypropyl)pyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)NCCCOC)Cl)N LNYPPWSTAATSNO-UHFFFAOYSA-N 0.000 claims 1
- MYBHJQAEMHMADJ-UHFFFAOYSA-N 4-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloro-N-methylpyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)NC)Cl)N MYBHJQAEMHMADJ-UHFFFAOYSA-N 0.000 claims 1
- XETBCFSFVAVHSU-UHFFFAOYSA-N 4-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)C XETBCFSFVAVHSU-UHFFFAOYSA-N 0.000 claims 1
- VDSCYAIYKXCNTR-UHFFFAOYSA-N 4-[2-(4-amino-4-propylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound CCCC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N VDSCYAIYKXCNTR-UHFFFAOYSA-N 0.000 claims 1
- GLSDSKWAUHMDKI-UHFFFAOYSA-N 4-[2-(4-aminopiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound NC1CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl GLSDSKWAUHMDKI-UHFFFAOYSA-N 0.000 claims 1
- VBHFFPWECGMYIJ-JOCHJYFZSA-N 4-[2-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3,3-difluoro-1H-pyrrolo[2,3-b]pyridin-2-one Chemical compound N[C@@H]1C2=CC=CC=C2CC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C2C(=NC=C1)NC(C2(F)F)=O VBHFFPWECGMYIJ-JOCHJYFZSA-N 0.000 claims 1
- FAUQRTFHFJINAV-GHMZBOCLSA-N 4-[2-[(2R,4R)-4-amino-2-methylpiperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound N[C@H]1C[C@H](N(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)C FAUQRTFHFJINAV-GHMZBOCLSA-N 0.000 claims 1
- URFJIKBVZWVJKK-OXPNAJOUSA-N 4-[2-[(2R,4S)-4-amino-2-methylpiperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine dihydrochloride Chemical compound C[C@@H]1C[C@H](CCN1C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N.Cl.Cl URFJIKBVZWVJKK-OXPNAJOUSA-N 0.000 claims 1
- WXHPSEMDCWLBRT-QWRGUYRKSA-N 4-[2-[(2S,5S)-5-amino-2-methylpiperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C[C@H]1CC[C@@H](CN1C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N WXHPSEMDCWLBRT-QWRGUYRKSA-N 0.000 claims 1
- YQZRAFURHWBDSG-ZWMPAUSASA-N 4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C2C(=NC=C1)C(CC2)O)C YQZRAFURHWBDSG-ZWMPAUSASA-N 0.000 claims 1
- SBVOQSQAUORQPM-UHFFFAOYSA-N 4-[2-[2-(aminomethyl)morpholin-4-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1COC(CN1C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)CN SBVOQSQAUORQPM-UHFFFAOYSA-N 0.000 claims 1
- ZOKNENPBEZVEMK-UHFFFAOYSA-N 4-[2-[3-(aminomethyl)-8-azabicyclo[3.2.1]octan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1CC2CC(CC1N2C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl)CN ZOKNENPBEZVEMK-UHFFFAOYSA-N 0.000 claims 1
- BMTRFZAVGOUDNH-UHFFFAOYSA-N 4-[2-[3-(aminomethyl)azetidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound NCC1CN(C1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl BMTRFZAVGOUDNH-UHFFFAOYSA-N 0.000 claims 1
- RCRFZYPPQFXDGT-UHFFFAOYSA-N 4-[2-[4-(2-aminopropan-2-yl)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound CC(C)(C1CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N RCRFZYPPQFXDGT-UHFFFAOYSA-N 0.000 claims 1
- QDFJAJXFZGROOS-UHFFFAOYSA-N 4-[2-[4-(aminomethyl)-4-fluoropiperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1CN(CCC1(CN)F)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl QDFJAJXFZGROOS-UHFFFAOYSA-N 0.000 claims 1
- FZVDMPMSYYNXLJ-UHFFFAOYSA-N 4-[2-[4-(aminomethyl)-4-methylpiperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound NCC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)N)Cl)C FZVDMPMSYYNXLJ-UHFFFAOYSA-N 0.000 claims 1
- SPGYXYQCINHEQF-UHFFFAOYSA-N 4-[2-[4-amino-4-(2-methoxyethyl)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound COCCC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N SPGYXYQCINHEQF-UHFFFAOYSA-N 0.000 claims 1
- HRUKFBHWYKVFJK-UHFFFAOYSA-N 4-[2-[4-amino-4-(methoxymethyl)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound COCC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl)N HRUKFBHWYKVFJK-UHFFFAOYSA-N 0.000 claims 1
- AAPIPFLTUXTWRG-UHFFFAOYSA-N 4-[2-[4-amino-4-(pyridin-2-ylmethyl)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1CN(CCC1(CC2=CC=CC=N2)N)C3=CN=C4C(=N3)C=CC(=N4)SC5=C(C(=NC=C5)N)Cl AAPIPFLTUXTWRG-UHFFFAOYSA-N 0.000 claims 1
- KIBCUZKHHHLHOO-UHFFFAOYSA-N 4-[2-[4-amino-4-(trifluoromethyl)piperidin-1-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-amine Chemical compound C1CN(CCC1(C(F)(F)F)N)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl KIBCUZKHHHLHOO-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- FOALSMGZULZWQC-UHFFFAOYSA-N 4-methyl-1-(6-pyrazolo[1,5-a]pyrazin-4-ylsulfanylpyrido[2,3-b]pyrazin-2-yl)piperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=NC=CN5C4=CC=N5)N FOALSMGZULZWQC-UHFFFAOYSA-N 0.000 claims 1
- TWNUZAYFKPTMKX-UHFFFAOYSA-N 4-methyl-1-(6-pyrazolo[1,5-a]pyridin-4-ylsulfanylpyrido[2,3-b]pyrazin-2-yl)piperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=CC=CN5C4=CC=N5)N TWNUZAYFKPTMKX-UHFFFAOYSA-N 0.000 claims 1
- IGHIYSOLOYLYSR-UHFFFAOYSA-N 4-methyl-1-[6-(1,8-naphthyridin-4-ylsulfanyl)pyrido[2,3-b]pyrazin-2-yl]piperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C5C=CC=NC5=NC=C4)N IGHIYSOLOYLYSR-UHFFFAOYSA-N 0.000 claims 1
- QIQRNYCEFOFLKE-UHFFFAOYSA-N 4-methyl-1-[6-(1-methylindazol-7-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=CC=CC5=C4N(N=C5)C)N QIQRNYCEFOFLKE-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- AMXHROSIWFNJQQ-UHFFFAOYSA-N 5-[2-(4-amino-4-methylpiperidin-1-yl)pyrido[2,3-b]pyrazin-6-yl]sulfanyl-6-chloropyridin-2-amine Chemical compound CC1(CCN(CC1)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(N=C(C=C4)N)Cl)N AMXHROSIWFNJQQ-UHFFFAOYSA-N 0.000 claims 1
- YJALGCHDTANYIC-UHFFFAOYSA-N 5-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-5-azaspiro[3.4]octan-2-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2C3(CC(C3)N)CCC2)N=1 YJALGCHDTANYIC-UHFFFAOYSA-N 0.000 claims 1
- JTHMPBOIFSACOL-UHFFFAOYSA-N 6-(2-amino-3-chloropyridin-4-yl)sulfanyl-N-[3-(aminomethyl)oxolan-3-yl]pyrido[2,3-b]pyrazin-2-amine Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)NC2(COCC2)CN)N=1 JTHMPBOIFSACOL-UHFFFAOYSA-N 0.000 claims 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 208000001446 Anaplastic Thyroid Carcinoma Diseases 0.000 claims 1
- 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- DKOXNNWWEUNXSA-QGZVFWFLSA-N C[C@@](CC1)(CN1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl)N Chemical compound C[C@@](CC1)(CN1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl)N DKOXNNWWEUNXSA-QGZVFWFLSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000032027 Essential Thrombocythemia Diseases 0.000 claims 1
- 208000032004 Large-Cell Anaplastic Lymphoma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 208000037538 Myelomonocytic Juvenile Leukemia Diseases 0.000 claims 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 1
- CFOPXWCJLPEYRO-UHFFFAOYSA-N NC(CC(C1)(F)F)C1(CC1)CCN1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl Chemical compound NC(CC(C1)(F)F)C1(CC1)CCN1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl CFOPXWCJLPEYRO-UHFFFAOYSA-N 0.000 claims 1
- ALPPVDSYBIAQBB-YHWZYXNKSA-N NC(C[C@H]1CCC2)C[C@H]2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl Chemical compound NC(C[C@H]1CCC2)C[C@H]2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl ALPPVDSYBIAQBB-YHWZYXNKSA-N 0.000 claims 1
- VOQZIHRPPGGUFQ-UHFFFAOYSA-N NCC(CC1CCC2)CC2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl Chemical compound NCC(CC1CCC2)CC2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl VOQZIHRPPGGUFQ-UHFFFAOYSA-N 0.000 claims 1
- YPLHAXDRIIJALD-JOCHJYFZSA-N N[C@@H](C(CC1=C2)(CC3)CCN3C(N=C3C=C4)=CN=C3N=C4SC(C=CN=C3N)=C3Cl)C1=CC=C2Cl Chemical compound N[C@@H](C(CC1=C2)(CC3)CCN3C(N=C3C=C4)=CN=C3N=C4SC(C=CN=C3N)=C3Cl)C1=CC=C2Cl YPLHAXDRIIJALD-JOCHJYFZSA-N 0.000 claims 1
- PDJJDVKTVCPUEB-SCVCMEIPSA-N N[C@@H](C[C@H]1CC2)[C@H]2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl Chemical compound N[C@@H](C[C@H]1CC2)[C@H]2N1C(N=C1C=C2)=CN=C1N=C2SC(C=CN=C1N)=C1Cl PDJJDVKTVCPUEB-SCVCMEIPSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 208000009905 Neurofibromatoses Diseases 0.000 claims 1
- 206010029748 Noonan syndrome Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- WDEQRHBPNCUNBM-UHFFFAOYSA-N [1-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-fluoropiperidin-4-yl]methanamine Chemical compound C1CN(CCC1(CN)F)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=CC=C4)Cl)Cl WDEQRHBPNCUNBM-UHFFFAOYSA-N 0.000 claims 1
- KALYOQJMJGAEMJ-UHFFFAOYSA-N [1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]-4-(aminomethyl)piperidin-4-yl]methanol Chemical compound NC1=NC=CC(=C1Cl)SC=1C=CC=2C(=NC=C(N=2)N2CCC(CC2)(CN)CO)N=1 KALYOQJMJGAEMJ-UHFFFAOYSA-N 0.000 claims 1
- QTWJJHGOWBPXTM-RNODOKPDSA-N [4-[2-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrido[2,3-b]pyrazin-6-yl]sulfanyl-3-chloropyridin-2-yl]methanol Chemical compound N[C@@H]1[C@@H](OCC11CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=NC=C1)CO)Cl)C QTWJJHGOWBPXTM-RNODOKPDSA-N 0.000 claims 1
- VJCQHPYOLRNERO-UHFFFAOYSA-N [4-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]morpholin-2-yl]methanamine Chemical compound C1COC(CN1C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=CC=C4)Cl)Cl)CN VJCQHPYOLRNERO-UHFFFAOYSA-N 0.000 claims 1
- BSPZAXYUYHMMPN-UHFFFAOYSA-N [4-amino-1-[6-(2,3-dichlorophenyl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]methanol Chemical compound NC1(CCN(CC1)C=1N=C2C(=NC=1)N=C(C=C2)SC1=C(C(=CC=C1)Cl)Cl)CO BSPZAXYUYHMMPN-UHFFFAOYSA-N 0.000 claims 1
- PCXDBZWVXCUNCB-UHFFFAOYSA-N [4-amino-1-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]methanol Chemical compound C1CN(CCC1(CO)N)C2=CN=C3C(=N2)C=CC(=N3)SC4=C(C(=NC=C4)N)Cl PCXDBZWVXCUNCB-UHFFFAOYSA-N 0.000 claims 1
- CJYBRLKDLCQQSJ-UHFFFAOYSA-N [4-amino-1-[6-(3-chloro-2-methoxypyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]methanol Chemical compound COC1=NC=CC(=C1Cl)SC2=NC3=NC=C(N=C3C=C2)N4CCC(CC4)(CO)N CJYBRLKDLCQQSJ-UHFFFAOYSA-N 0.000 claims 1
- PFQHOPYKRJZPHP-UHFFFAOYSA-N [4-amino-1-[6-(3-chloro-2-methylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]methanol Chemical compound CC1=NC=CC(=C1Cl)SC2=NC3=NC=C(N=C3C=C2)N4CCC(CC4)(CO)N PFQHOPYKRJZPHP-UHFFFAOYSA-N 0.000 claims 1
- YCNFSTRINHKBCF-UHFFFAOYSA-N [4-amino-1-[6-(3-chloro-2-pyrrolidin-1-ylpyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]piperidin-4-yl]methanol Chemical compound C1CCN(C1)C2=NC=CC(=C2Cl)SC3=NC4=NC=C(N=C4C=C3)N5CCC(CC5)(CO)N YCNFSTRINHKBCF-UHFFFAOYSA-N 0.000 claims 1
- 208000017733 acquired polycythemia vera Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 201000005992 juvenile myelomonocytic leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 206010028537 myelofibrosis Diseases 0.000 claims 1
- 201000004931 neurofibromatosis Diseases 0.000 claims 1
- JASMWYNKLTULAN-UHFFFAOYSA-N octan-3-amine Chemical compound CCCCCC(N)CC JASMWYNKLTULAN-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000037244 polycythemia vera Diseases 0.000 claims 1
- 208000003476 primary myelofibrosis Diseases 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 208000017572 squamous cell neoplasm Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 201000008440 thyroid gland anaplastic carcinoma Diseases 0.000 claims 1
- 208000019179 thyroid gland undifferentiated (anaplastic) carcinoma Diseases 0.000 claims 1
- VSRBKQFNFZQRBM-UHFFFAOYSA-N tuaminoheptane Chemical compound CCCCCC(C)N VSRBKQFNFZQRBM-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746952P | 2018-10-17 | 2018-10-17 | |
| US62/746,952 | 2018-10-17 | ||
| US201962916119P | 2019-10-16 | 2019-10-16 | |
| US62/916,119 | 2019-10-16 | ||
| PCT/US2019/056786 WO2020081848A1 (en) | 2018-10-17 | 2019-10-17 | Protein tyrosine phosphatase inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022504936A JP2022504936A (ja) | 2022-01-13 |
| JPWO2020081848A5 true JPWO2020081848A5 (https=) | 2022-10-07 |
| JP2022504936A5 JP2022504936A5 (https=) | 2022-10-07 |
| JP7449282B2 JP7449282B2 (ja) | 2024-03-13 |
Family
ID=68536896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520556A Active JP7449282B2 (ja) | 2018-10-17 | 2019-10-17 | タンパク質チロシンホスファターゼ阻害薬 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US12187721B2 (https=) |
| EP (1) | EP3867238B1 (https=) |
| JP (1) | JP7449282B2 (https=) |
| KR (1) | KR102649419B1 (https=) |
| CN (1) | CN114341124B (https=) |
| AU (1) | AU2019359885B2 (https=) |
| BR (1) | BR112021005733A2 (https=) |
| CA (1) | CA3116561C (https=) |
| CL (1) | CL2021000972A1 (https=) |
| CO (1) | CO2021004966A2 (https=) |
| CR (1) | CR20210189A (https=) |
| CU (1) | CU20210029A7 (https=) |
| CY (1) | CY1126122T1 (https=) |
| DO (1) | DOP2021000070A (https=) |
| EC (1) | ECSP21027049A (https=) |
| ES (1) | ES2947464T3 (https=) |
| HU (1) | HUE062404T2 (https=) |
| IL (1) | IL282179B2 (https=) |
| MA (1) | MA53921A (https=) |
| MX (1) | MX2021004410A (https=) |
| NI (1) | NI202100027A (https=) |
| PE (1) | PE20211465A1 (https=) |
| PH (1) | PH12021550674A1 (https=) |
| PL (1) | PL3867238T3 (https=) |
| SG (1) | SG11202102985YA (https=) |
| WO (1) | WO2020081848A1 (https=) |
| ZA (1) | ZA202101960B (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11529347B2 (en) | 2016-09-22 | 2022-12-20 | Relay Therapeutics, Inc. | SHP2 phosphatase inhibitors and methods of use thereof |
| TW202500565A (zh) | 2016-10-24 | 2025-01-01 | 美商傳達治療有限公司 | Shp2磷酸酶抑制劑及其使用方法 |
| WO2018218133A1 (en) | 2017-05-26 | 2018-11-29 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
| EP3687997A1 (en) | 2017-09-29 | 2020-08-05 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
| WO2019183364A1 (en) | 2018-03-21 | 2019-09-26 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof |
| SG11202009245TA (en) | 2018-03-21 | 2020-10-29 | Relay Therapeutics Inc | Shp2 phosphatase inhibitors and methods of use thereof |
| WO2020072656A1 (en) | 2018-10-03 | 2020-04-09 | Gilead Sciences, Inc. | Imidozopyrimidine derivatives |
| WO2020201991A1 (en) | 2019-04-02 | 2020-10-08 | Array Biopharma Inc. | Protein tyrosine phosphatase inhibitors |
| AU2020354475A1 (en) | 2019-09-24 | 2022-05-05 | Relay Therapeutics, Inc. | SHP2 phosphatase inhibitors and methods of making and using the same |
| TW202128688A (zh) | 2019-11-08 | 2021-08-01 | 美商銳新醫藥公司 | 雙環雜芳基化合物及其用途 |
| IL299131A (en) | 2020-06-18 | 2023-02-01 | Revolution Medicines Inc | Methods for delaying, preventing and treating acquired resistance to RAS inhibitors |
| MX2023002248A (es) | 2020-09-03 | 2023-05-16 | Revolution Medicines Inc | Uso de inhibidores de sos1 para tratar neoplasias malignas con mutaciones de shp2. |
| MX2023003060A (es) | 2020-09-15 | 2023-04-05 | Revolution Medicines Inc | Derivados indolicos como inhibidores de ras en el tratamiento del cancer. |
| TWI825637B (zh) | 2021-03-31 | 2023-12-11 | 美商輝瑞股份有限公司 | 啶－１，６（２ｈ，７ｈ）－二酮 |
| CA3217393A1 (en) | 2021-05-05 | 2022-11-10 | Elena S. Koltun | Ras inhibitors |
| AU2022268962A1 (en) | 2021-05-05 | 2023-12-14 | Revolution Medicines, Inc. | Ras inhibitors for the treatment of cancer |
| WO2022235866A1 (en) | 2021-05-05 | 2022-11-10 | Revolution Medicines, Inc. | Covalent ras inhibitors and uses thereof |
| TW202244049A (zh) * | 2021-05-12 | 2022-11-16 | 大陸商藥雅科技（上海）有限公司 | Shp2磷酸酶抑制劑的製備及其應用 |
| CN115960109B (zh) * | 2021-05-31 | 2024-06-25 | 药雅科技(上海)有限公司 | 稠环类shp2磷酸酶抑制剂的制备及其应用 |
| CN115340561A (zh) * | 2021-05-14 | 2022-11-15 | 药雅科技(上海)有限公司 | Shp2磷酸酶稠环类抑制剂的制备及其应用 |
| WO2022259157A1 (en) | 2021-06-09 | 2022-12-15 | Novartis Ag | A triple pharmaceutical combination comprising dabrafenib, trametinib and a shp2 inhibitor |
| TW202317100A (zh) | 2021-06-23 | 2023-05-01 | 瑞士商諾華公司 | 包含ｋｒａｓ ｇ１２ｃ抑制劑的藥物組合及其用於治療癌症之用途 |
| CA3226206A1 (en) | 2021-07-09 | 2023-01-12 | Kanaph Therapeutics Inc. | Shp2 inhibitor and use thereof |
| CA3224341A1 (en) | 2021-09-01 | 2023-03-09 | Novartis Ag | Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers |
| AR127308A1 (es) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | Inhibidores ras |
| TW202346305A (zh) * | 2022-01-05 | 2023-12-01 | 美商雷密克斯醫療公司 | 用於調節剪切之化合物及方法 |
| CN119136806A (zh) | 2022-03-08 | 2024-12-13 | 锐新医药公司 | 用于治疗免疫难治性肺癌的方法 |
| CN116731038B (zh) * | 2022-03-10 | 2025-11-21 | 苏州亚盛药业有限公司 | 含氮杂环化合物及其制备方法和应用 |
| CN114621186A (zh) * | 2022-05-12 | 2022-06-14 | 上海维申医药有限公司 | 作为ras信号通路调控剂的杂环化合物 |
| IL316768A (en) | 2022-05-25 | 2025-01-01 | Ikena Oncology Inc | MEK inhibitors and their uses |
| WO2023240263A1 (en) | 2022-06-10 | 2023-12-14 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| EP4687905A1 (en) | 2023-03-30 | 2026-02-11 | Revolution Medicines, Inc. | Compositions for inducing ras gtp hydrolysis and uses thereof |
| KR20260005904A (ko) | 2023-04-07 | 2026-01-12 | 레볼루션 메디슨즈, 인크. | 매크로사이클릭 ras 억제제 |
| CN121263418A (zh) | 2023-04-07 | 2026-01-02 | 锐新医药公司 | 大环ras抑制剂 |
| KR20250172857A (ko) | 2023-04-14 | 2025-12-09 | 레볼루션 메디슨즈, 인크. | Ras 억제제의 결정형 |
| AU2024252105A1 (en) | 2023-04-14 | 2025-10-16 | Revolution Medicines, Inc. | Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof |
| WO2024218632A1 (en) | 2023-04-17 | 2024-10-24 | Array Biopharma Inc. | Erk protein kinase inhibitors |
| AU2024265078A1 (en) | 2023-05-04 | 2025-12-11 | Revolution Medicines, Inc. | Combination therapy for a ras related disease or disorder |
| IL326136A (en) | 2023-08-07 | 2026-03-01 | Revolution Medicines Inc | RMC-6291 for use in the treatment of a disease or disorder associated with the RAS protein |
| US20250154171A1 (en) | 2023-10-12 | 2025-05-15 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025190395A2 (en) * | 2024-03-14 | 2025-09-18 | Pharmaengine, Inc. | Mta-cooperative prmt5 inhibitor |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| WO2004052371A2 (en) | 2002-12-11 | 2004-06-24 | 7Tm Pharma A/S | Cyclic quinoline compounds for use in mch receptor related disorders |
| WO2005007099A2 (en) | 2003-07-10 | 2005-01-27 | Imclone Systems Incorporated | Pkb inhibitors as anti-tumor agents |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| WO2006050501A2 (en) | 2004-11-03 | 2006-05-11 | University Of Kansas | Novobiocin analogues as anticancer agents |
| WO2007029847A1 (ja) * | 2005-09-07 | 2007-03-15 | Banyu Pharmaceutical Co., Ltd. | 二環性芳香族置換ピリドン誘導体 |
| CA2651072A1 (en) | 2006-05-01 | 2007-11-08 | Pfizer Products Inc. | Substituted 2-amino-fused heterocyclic compounds |
| US20100016293A1 (en) | 2006-07-03 | 2010-01-21 | Rogier Adriaan Smits | Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| EP1990342A1 (en) | 2007-05-10 | 2008-11-12 | AEterna Zentaris GmbH | Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof |
| JP2011510018A (ja) | 2008-01-18 | 2011-03-31 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 癌治療のためのイミダゾピラジノール誘導体 |
| EP2427195B1 (en) | 2009-05-07 | 2019-05-01 | Intellikine, LLC | Heterocyclic compounds and uses thereof |
| PE20121148A1 (es) | 2009-08-17 | 2012-09-07 | Intellikine Llc | Compuestos heterociclicos y usos de los mismos |
| WO2011032050A2 (en) * | 2009-09-11 | 2011-03-17 | Trius Therapeutics, Inc. | Gyrase inhibitors |
| US9096590B2 (en) * | 2010-05-24 | 2015-08-04 | Intellikine Llc | Substituted benzoxazoles as PI3 kinase inhibitors |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| US20120225846A1 (en) | 2011-03-02 | 2012-09-06 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| HK1202333A1 (en) | 2011-11-11 | 2015-09-25 | Intellikine, Llc | Combination of kinase inhibitors and uses thereof |
| EP2968340A4 (en) | 2013-03-15 | 2016-08-10 | Intellikine Llc | COMBINING KINASE INHIBITORS AND USES THEREOF |
| CN105899493B (zh) | 2014-01-17 | 2019-03-29 | 诺华股份有限公司 | 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物 |
| JP6523303B2 (ja) | 2014-01-17 | 2019-05-29 | ノバルティス アーゲー | Ｓｈｐ２の活性を阻害するための１−ピリダジン／トリアジン−３−イル−ピペラジン／ピペリジン／ピロリジン誘導体およびその組成物 |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| ES2824576T3 (es) | 2015-06-19 | 2021-05-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
| ES2741746T3 (es) | 2015-06-19 | 2020-02-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
| CN112625028B (zh) | 2015-06-19 | 2024-10-29 | 诺华股份有限公司 | 用于抑制shp2活性的化合物和组合物 |
| AU2017274199B2 (en) | 2016-05-31 | 2021-09-23 | Board Of Regents, The University Of Texas System | Heterocyclic inhibitors of PTPN11 |
| EA202092441A1 (ru) | 2016-06-07 | 2021-05-21 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| MX383856B (es) | 2016-06-14 | 2025-03-14 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de shp2. |
| KR102598895B1 (ko) | 2016-07-12 | 2023-11-07 | 레볼루션 메디슨즈, 인크. | 다른자리 입체성 shp2 억제제로서의 2,5-이치환 3-메틸 피라진 및 2,5,6-3치환 3-메틸 피라진 |
| US11529347B2 (en) * | 2016-09-22 | 2022-12-20 | Relay Therapeutics, Inc. | SHP2 phosphatase inhibitors and methods of use thereof |
| TW202500565A (zh) * | 2016-10-24 | 2025-01-01 | 美商傳達治療有限公司 | Shp2磷酸酶抑制劑及其使用方法 |
| MX2019008696A (es) | 2017-01-23 | 2019-09-13 | Revolution Medicines Inc | Compuestos de piridina como inhibidores de shp2 alostericos. |
| MX2019008695A (es) | 2017-01-23 | 2019-09-11 | Revolution Medicines Inc | Compuestos biciclicos como inhibidores alostericos de shp2. |
| KR20240026521A (ko) | 2017-03-23 | 2024-02-28 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| WO2018218133A1 (en) | 2017-05-26 | 2018-11-29 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
| CA3074690A1 (en) | 2017-09-07 | 2019-03-14 | Revolution Medicines, Inc. | Shp2 inhibitor compositions and methods for treating cancer |
| WO2019051469A1 (en) | 2017-09-11 | 2019-03-14 | Krouzon Pharmaceuticals, Inc. | Octahydrocyclopenta[c]pyrrole allosteric inhibitors of shp2 |
| EP3687997A1 (en) | 2017-09-29 | 2020-08-05 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
| MX2020003579A (es) | 2017-10-12 | 2020-07-22 | Revolution Medicines Inc | Compuestos de piridina, pirazina, y triazina como inhibidores de shp2 alostericos. |
| BR112020009757A2 (pt) | 2017-12-15 | 2020-11-03 | Revolution Medicines, Inc. | compostos policíclicos como inibidores alostéricos de shp2 |
| US11426422B2 (en) | 2018-01-30 | 2022-08-30 | Research Development Foundation | SHP2 inhibitors and methods of use thereof |
| RU2020133727A (ru) | 2018-03-21 | 2022-04-21 | Сучжоу Пухе Биофарма Ко., Лтд. | Ингибиторы shp2 и их применение |
| WO2019183364A1 (en) | 2018-03-21 | 2019-09-26 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof |
| SG11202009245TA (en) | 2018-03-21 | 2020-10-29 | Relay Therapeutics Inc | Shp2 phosphatase inhibitors and methods of use thereof |
| US20210230300A1 (en) | 2018-06-04 | 2021-07-29 | Bayer Aktiengesellschaft | Inhibitors of shp2 |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| CN113473990A (zh) | 2018-10-08 | 2021-10-01 | 锐新医药公司 | 用于治疗癌症的shp2抑制剂组合物 |
| WO2020201991A1 (en) | 2019-04-02 | 2020-10-08 | Array Biopharma Inc. | Protein tyrosine phosphatase inhibitors |
-
2019
- 2019-10-17 US US17/285,997 patent/US12187721B2/en active Active
- 2019-10-17 IL IL282179A patent/IL282179B2/en unknown
- 2019-10-17 AU AU2019359885A patent/AU2019359885B2/en active Active
- 2019-10-17 CR CR20210189A patent/CR20210189A/es unknown
- 2019-10-17 MA MA053921A patent/MA53921A/fr unknown
- 2019-10-17 KR KR1020217014574A patent/KR102649419B1/ko active Active
- 2019-10-17 SG SG11202102985YA patent/SG11202102985YA/en unknown
- 2019-10-17 CU CU2021000029A patent/CU20210029A7/es unknown
- 2019-10-17 WO PCT/US2019/056786 patent/WO2020081848A1/en not_active Ceased
- 2019-10-17 JP JP2021520556A patent/JP7449282B2/ja active Active
- 2019-10-17 EP EP19801996.0A patent/EP3867238B1/en active Active
- 2019-10-17 CA CA3116561A patent/CA3116561C/en active Active
- 2019-10-17 CN CN201980068343.2A patent/CN114341124B/zh active Active
- 2019-10-17 PL PL19801996.0T patent/PL3867238T3/pl unknown
- 2019-10-17 ES ES19801996T patent/ES2947464T3/es active Active
- 2019-10-17 MX MX2021004410A patent/MX2021004410A/es unknown
- 2019-10-17 BR BR112021005733-1A patent/BR112021005733A2/pt unknown
- 2019-10-17 PE PE2021000527A patent/PE20211465A1/es unknown
- 2019-10-17 HU HUE19801996A patent/HUE062404T2/hu unknown
-
2021
- 2021-03-24 ZA ZA2021/01960A patent/ZA202101960B/en unknown
- 2021-03-25 PH PH12021550674A patent/PH12021550674A1/en unknown
- 2021-04-16 NI NI202100027A patent/NI202100027A/es unknown
- 2021-04-16 CL CL2021000972A patent/CL2021000972A1/es unknown
- 2021-04-16 DO DO2021000070A patent/DOP2021000070A/es unknown
- 2021-04-16 EC ECSENADI202127049A patent/ECSP21027049A/es unknown
- 2021-04-19 CO CONC2021/0004966A patent/CO2021004966A2/es unknown
-
2023
- 2023-08-01 CY CY20231100379T patent/CY1126122T1/el unknown
-
2024
- 2024-11-13 US US18/946,138 patent/US20250066357A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020081848A5 (https=) | ||
| KR101812357B1 (ko) | Ｃｄｋ4/6의 억제제로서의 피롤로피리미딘 화합물 | |
| AU2019359885B2 (en) | Protein tyrosine phosphatase inhibitors | |
| JP6631616B2 (ja) | ＣＤＫ阻害剤としての２−アミノ−ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン誘導体及びその使用 | |
| AU2022265682A1 (en) | 2-aminobenzothiazole compounds and methods of use thereof | |
| DK3176170T3 (en) | SUBSTITUTED TRICYCLIC RELATIONS AS FGFR INHIBITORS | |
| TW202423440A (zh) | Ｋｒａｓ ｇ１２ｃ突變蛋白的系鏈之雜環抑制劑及其用途 | |
| JP2021528466A5 (https=) | ||
| JP2022527796A5 (https=) | ||
| RU2020133727A (ru) | Ингибиторы shp2 и их применение | |
| JP2015521600A5 (https=) | ||
| JPWO2019191092A5 (https=) | ||
| HRP20230120T1 (hr) | Inhibitori bcl6 | |
| WO2024215862A2 (en) | Heterocyclic compounds as nras inhibitors | |
| JP2025538097A (ja) | がんを処置するための方法 | |
| JPWO2019197842A5 (https=) | ||
| JPWO2019233941A5 (https=) | ||
| JPWO2020207991A5 (https=) | ||
| WO2025217247A1 (en) | Tethered spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| JPWO2022013136A5 (https=) | ||
| RU2023134860A (ru) | Ингибиторы мутации her2 | |
| WO2025194057A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof | |
| NZ771342A (en) | Heteroaryl compounds for treating huntington’s disease | |
| NZ771342B2 (en) | Heteroaryl compounds for treating huntington's disease | |
| RU2020142969A (ru) | СОЕДИНЕНИЯ ТЕТРАГИДРО-1Н-ПИРАЗИНО[2,1- a]ИЗОИНДОЛИЛХИНОЛИНА ДЛЯ ЛЕЧЕНИЯ АУТОИММУННОГО ЗАБОЛЕВАНИЯ |